Monitoring after childhood cancer--an update for GPs.
BACKGROUND
The majority of children treated for a cancer will be long term survivors, with the potential to develop specific treatment related adverse health outcomes.


OBJECTIVE
This article describes the late effects of treatments for childhood cancer, and makes recommendations about appropriate surveillance.


CONCLUSIONS
With appropriate primary care input, long term morbidity and mortality for childhood cancer survivors can be reduced.
Heath
John A
JA
Children's Cancer Centre, Royal Children's Hospital, Melbourne, Victoria, Australia. john.heath@rch.org.au
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D003072:Cognition Disorders / Q000209:etiology / Q000517:prevention & control; D004700:Endocrine System Diseases / Q000209:etiology / Q000517:prevention & control; D005194:Family Practice / Q000379:methods*; D005260:Female; D005298:Fertility; D006130:Growth Disorders / Q000209:etiology / Q000517:prevention & control; D006293:Health Promotion / Q000379:methods; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D009369:Neoplasms / Q000150:complications / Q000523:psychology / Q000534:rehabilitation*; D016609:Neoplasms, Second Primary; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D017741:Survivors
D000970:Antineoplastic Agents